Komori
Riken Keiki (7734) · InitiativeDropped

Preventing COVID-19 Infection Through Remote Work and Other Measures

First written in FY2020. 9 of 13 entries say "Restated". Latest entry: FY2024.

13entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2020 – FY2021-Q3RestatedFY2022-Q1 – FY2023-Q3SoftenedFY20232020: 320202021: 420212022: 320222023: 220232024: 12024
Same theme, other companies
Response to COVID-19 and Transformation of Work StylesA theme 829 companies write about · 231 as a headwind · 549 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 833 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2024DroppedAnnual report

    「Following COVID-19's reclassification as a Category V infectious disease on 8 May 2023, the company discontinued its internal response structure for preventing the spread of COVID-19 and ended its infection-prevention measures.」

    The company ended COVID-19 infection-prevention measures, including working from home, staggered working hours and web conferences, and discontinued its response structure.
  2. FY2023SoftenedAnnual report

    「COVID-19 was reclassified as a Category V infectious disease on 8 May 2023, and the company has also changed from working from home to working in the office」

    The company stated that it had changed from working from home to working in the office while continuing infection-prevention measures, indicating a reduced emphasis on a remote-work-centered response.
  3. FY2023-Q3RestatedAnnual report

    「Amid these conditions, the Group has continued to implement measures to prevent infection with the novel coronavirus, reduce costs through production rationalization, implement thorough expense reductions, develop sales activities using online channels, actively invest in new product development, and strengthen its quality control and service systems.」

    The company continues to implement COVID-19 infection-prevention measures. This disclosure does not specify the measures used.
  4. FY2023-Q2RestatedAnnual report

    「Amid these conditions, the Group has continued to implement measures to prevent infection with the novel coronavirus, reduce costs through production rationalization, implement thorough expense reductions, develop sales activities using online channels, actively invest in new product development, and strengthen its quality control and service systems.」

    The company continues to implement COVID-19 infection-prevention measures. This disclosure does not specify the measures used.
  5. FY2023-Q1RestatedAnnual report

    「Amid these conditions, the Group has continued to implement measures to prevent infection with the novel coronavirus, reduce costs through production rationalization, implement thorough expense reductions, develop sales activities using online channels, actively invest in new product development, and strengthen its quality control and service systems.」

    The company continues to implement COVID-19 infection-prevention measures. This disclosure does not specify the measures used.
  6. FY2022-Q3RestatedAnnual report

    「Amid these conditions, the Group has continued to implement measures to prevent infection with the novel coronavirus, reduce costs through production rationalization, implement thorough expense reductions, develop sales activities using online channels, actively invest in new product development, and strengthen its quality control and service systems.」

    The company continues to implement COVID-19 infection-prevention measures. This disclosure does not specify the measures used.
  7. FY2022-Q2RestatedAnnual report

    「Amid these conditions, the Group has continued to implement measures to prevent infection with the novel coronavirus, reduce costs through production rationalization, implement thorough expense reductions, develop sales activities using online channels, actively invest in new product development, and strengthen its quality control and service systems.」

    The company continues to implement COVID-19 infection-prevention measures.
  8. FY2022-Q1RestatedAnnual report

    「In addition to implementing COVID-19 infection-prevention measures, the group has continued efforts to reduce costs through production rationalization, pursue thorough expense reductions, expand online sales activities, actively invest in new product development, and enhance its quality-control and service systems.」

    The company continues to implement COVID-19 infection-prevention measures.
  9. FY2021AdvancedAnnual report

    「Since the state of emergency was declared on 7 April last year, the company has strengthened COVID-19 infection-prevention measures at all sites, including working from home, staggered working hours and the use of web conference systems」

    In addition to its existing infection-prevention measures, the company specifically described working from home, staggered working hours and the use of web conference systems at all sites.
  10. FY2021-Q3RestatedAnnual report

    「Amid these conditions, the Group has continued to implement measures to prevent infection with the novel coronavirus, reduce costs through production rationalization, implement thorough expense reductions, develop sales activities using online channels, actively invest in new product development, and strengthen its quality control and service systems.」

    The company continues to implement COVID-19 infection-prevention measures.
  11. FY2021-Q2RestatedAnnual report

    「Amid these conditions, the Group has continued to implement measures to prevent infection with the novel coronavirus, reduce costs through production rationalization, implement thorough expense reductions, develop sales activities using online channels, actively invest in new product development, and strengthen its quality control and service systems.」

    While continuing to implement COVID-19 infection-prevention measures, the company continues its efforts to rationalize production, reduce expenses, conduct sales activities online, invest in new product development, and enhance its quality and service systems.
  12. FY2021-Q1RestatedAnnual report

    「Amid these conditions, the Group has continued to implement measures to prevent infection with the novel coronavirus, reduce costs through production rationalization, implement thorough expense reductions, develop sales activities using online channels, actively invest in new product development, and strengthen its quality control and service systems.」

    The company continues to implement COVID-19 infection-prevention measures, but this disclosure does not specify the measures used.
  13. FY2020First statedAnnual report

    「The company has implemented infection-prevention measures, including promoting remote work, and will continue working to contain the spread of infection.」

    The company identified infection-prevention measures, including promoting remote work, for the first time as a means of addressing COVID-19.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Riken Keiki's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.